A new approach to treatment of acute myelogenous leukemia using targeted therapy in combination with standard chemotherapy.
Jordan
Craig T
CT
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D016207:Cytokines / Q000235:genetics / Q000378:metabolism; D004167:Diphtheria Toxin / Q000235:genetics / Q000378:metabolism; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage
D016207:Cytokines; D004167:Diphtheria Toxin; D011993:Recombinant Fusion Proteins; D003561:Cytarabine